EMEA (Europe, Middle East and Africa) Biosimilar Monoclonal Antibodies Industry 2018 Market Research Report

Published: May, 2018 | Pages: 118 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the EMEA Biosimilar Monoclonal Antibodies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Biosimilar Monoclonal Antibodies for these regions, from 2013 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biosimilar Monoclonal Antibodies market competition by top manufacturers/players, with Biosimilar Monoclonal Antibodies sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    ProMab Biotechnologies
    Allergan plc
    Abbott
    BioXpress Therapeutics
    Bayer
    Bio Farma
    Merck
    Therapeutics
    Biocon
    Boehringer Ingelheim
    Celltrion Inc.
    Coherus BioSciences Inc.
    Zydus-Cadila
    Genor BioPharma
    Intas Pharmaceuticals
    Novartis
    Pfizer
    Reliance Life Sciences

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Infliximab
    Rituximab
    Abciximab
    Trastuzumab
    Adalimumab
    Bevacizumab

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiency
    Infectious Diseases
    Others

 Table of Contents

EMEA (Europe, Middle East and Africa) Biosimilar Monoclonal Antibodies Market Report 2018
1 Biosimilar Monoclonal Antibodies Overview
    1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
    1.2 Classification of Biosimilar Monoclonal Antibodies
        1.2.1 EMEA Biosimilar Monoclonal Antibodies Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 EMEA Biosimilar Monoclonal Antibodies Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 Infliximab
        1.2.4 Rituximab
        1.2.5 Abciximab
        1.2.6 Trastuzumab
        1.2.7 Adalimumab
        1.2.8 Bevacizumab
    1.3 EMEA Biosimilar Monoclonal Antibodies Market by Application/End Users
        1.3.1 EMEA Biosimilar Monoclonal Antibodies Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.2 Oncology
        1.3.3 Chronic and Autoimmune Diseases
        1.3.4 Growth Hormone Deficiency
        1.3.5 Infectious Diseases
        1.3.6 Others
    1.4 EMEA Biosimilar Monoclonal Antibodies Market by Region
        1.4.1 EMEA Biosimilar Monoclonal Antibodies Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 Europe Status and Prospect (2013-2025)
        1.4.3 Middle East Status and Prospect (2013-2025)
        1.4.4 Africa Status and Prospect (2013-2025)
    1.5 EMEA Market Size (Value and Volume) of Biosimilar Monoclonal Antibodies (2013-2025)
        1.5.1 EMEA Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2025)
        1.5.2 EMEA Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2025)

2 EMEA Biosimilar Monoclonal Antibodies Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Biosimilar Monoclonal Antibodies Market Competition by Players/Manufacturers
        2.1.1 EMEA Biosimilar Monoclonal Antibodies Sales Volume and Market Share of Major Players (2013-2018)
        2.1.2 EMEA Biosimilar Monoclonal Antibodies Revenue and Share by Players (2013-2018)
        2.1.3 EMEA Biosimilar Monoclonal Antibodies Sale Price by Players (2013-2018)
    2.2 EMEA Biosimilar Monoclonal Antibodies (Volume and Value) by Type/Product Category
        2.2.1 EMEA Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
        2.2.2 EMEA Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
        2.2.3 EMEA Biosimilar Monoclonal Antibodies Sale Price by Type (2013-2018)
    2.3 EMEA Biosimilar Monoclonal Antibodies (Volume) by Application
    2.4 EMEA Biosimilar Monoclonal Antibodies (Volume and Value) by Region
        2.4.1 EMEA Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2013-2018)
        2.4.2 EMEA Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2013-2018)
        2.4.3 EMEA Biosimilar Monoclonal Antibodies Sales Price by Region (2013-2018)

3 Europe Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        3.1.1 Europe Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2013-2018)
        3.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    3.2 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Type
    3.3 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Application
    3.4 Europe Biosimilar Monoclonal Antibodies Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Biosimilar Monoclonal Antibodies Sales Volume by Countries (2013-2018)
        3.4.2 Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
        3.4.3 Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        3.4.4 France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        3.4.5 UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        3.4.6 Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        3.4.7 Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        3.4.8 Benelux Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

4 Middle East Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        4.1.1 Middle East Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2013-2018)
        4.1.2 Middle East Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    4.2 Middle East Biosimilar Monoclonal Antibodies Sales and Market Share by Type
    4.3 Middle East Biosimilar Monoclonal Antibodies Sales and Market Share by Application
    4.4 Middle East Biosimilar Monoclonal Antibodies Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Biosimilar Monoclonal Antibodies Sales Volume by Countries (2013-2018)
        4.4.2 Middle East Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
        4.4.3 Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        4.4.4 Israel Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        4.4.5 UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        4.4.6 Iran Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

5 Africa Biosimilar Monoclonal Antibodies (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
        5.1.1 Africa Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2013-2018)
        5.1.2 Africa Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    5.2 Africa Biosimilar Monoclonal Antibodies Sales and Market Share by Type
    5.3 Africa Biosimilar Monoclonal Antibodies Sales and Market Share by Application
    5.4 Africa Biosimilar Monoclonal Antibodies Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Biosimilar Monoclonal Antibodies Sales Volume by Countries (2013-2018)
        5.4.2 Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
        5.4.3 South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        5.4.4 Nigeria Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        5.4.5 Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
        5.4.6 Algeria Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

6 EMEA Biosimilar Monoclonal Antibodies Manufacturers/Players Profiles and Sales Data
    6.1 ProMab Biotechnologies
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 Allergan plc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Allergan plc Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 Abbott
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Abbott Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    6.4 BioXpress Therapeutics
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.4.4 Main Business/Business Overview
    6.5 Bayer
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bayer Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.5.4 Main Business/Business Overview
    6.6 Bio Farma
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Bio Farma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.6.4 Main Business/Business Overview
    6.7 Merck
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.7.4 Main Business/Business Overview
    6.8 Therapeutics
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Therapeutics Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.8.4 Main Business/Business Overview
    6.9 Biocon
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Biocon Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.9.4 Main Business/Business Overview
    6.10 Boehringer Ingelheim
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2013-2018)
        6.10.4 Main Business/Business Overview
    6.11 Celltrion Inc.
    6.12 Coherus BioSciences Inc.
    6.13 Zydus-Cadila
    6.14 Genor BioPharma
    6.15 Intas Pharmaceuticals
    6.16 Novartis
    6.17 Pfizer
    6.18 Reliance Life Sciences

7 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
    7.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Biosimilar Monoclonal Antibodies Market Forecast (2018-2025)
    11.1 EMEA Biosimilar Monoclonal Antibodies Sales, Revenue and Price Forecast (2018-2025)
        11.1.1 EMEA Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2018-2025)
        11.1.2 EMEA Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2018-2025)
        11.1.3 EMEA Biosimilar Monoclonal Antibodies Price and Trend Forecast (2018-2025)
    11.2 EMEA Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.3 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.4 Middle Eastt Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.5 Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.6 EMEA Biosimilar Monoclonal Antibodies Sales Forecast by Type (2018-2025)
    11.7 EMEA Biosimilar Monoclonal Antibodies Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Biosimilar Monoclonal Antibodies
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Type (2013-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Volume Market Share by Type (Product Category) in 2017
    Figure Infliximab Product Picture
    Figure Rituximab Product Picture
    Figure Abciximab Product Picture
    Figure Trastuzumab Product Picture
    Figure Adalimumab Product Picture
    Figure Bevacizumab Product Picture
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Application (2013-2025)
    Figure EMEA Sales Market Share of Biosimilar Monoclonal Antibodies by Application in 2017
    Figure Oncology Examples
    Table Key Downstream Customer in Oncology
    Figure Chronic and Autoimmune Diseases Examples
    Table Key Downstream Customer in Chronic and Autoimmune Diseases
    Figure Growth Hormone Deficiency Examples
    Table Key Downstream Customer in Growth Hormone Deficiency
    Figure Infectious Diseases Examples
    Table Key Downstream Customer in Infectious Diseases
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure EMEA Biosimilar Monoclonal Antibodies Market Size (Million USD) by Region (2013-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Middle East Biosimilar Monoclonal Antibodies Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Volume and Growth Rate (2013-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Market Major Players Product Sales Volume (K Units) (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Sales Volume (K Units) of Major Players (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Sales Share by Players (2013-2018)
    Figure 2017 Biosimilar Monoclonal Antibodies Sales Share by Players
    Figure 2017 Biosimilar Monoclonal Antibodies Sales Share by Players
    Figure EMEA Biosimilar Monoclonal Antibodies Market Major Players Product Revenue (Million USD) (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Revenue (Million USD) by Players (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Revenue Share by Players (2013-2018)
    Table 2017 EMEA Biosimilar Monoclonal Antibodies Revenue Share by Players
    Table 2017 EMEA Biosimilar Monoclonal Antibodies Revenue Share by Players
    Table EMEA Biosimilar Monoclonal Antibodies Sale Price (USD/Unit) by Players (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Sales (K Units) and Market Share by Type (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Sales Share by Type (2013-2018)
    Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Revenue (Million USD) and Market Share by Type (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type in 2017
    Table EMEA Biosimilar Monoclonal Antibodies Sale Price (USD/Unit) by Type (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Sales (K Units) and Market Share by Application (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Sales Share by Application (2013-2018)
    Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Application (2013-2018)
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2017
    Table EMEA Biosimilar Monoclonal Antibodies Sales (K Units) and Market Share by Region (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Sales Share by Region (2013-2018)
    Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Region (2013-2018)
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Market Share in 2017
    Table EMEA Biosimilar Monoclonal Antibodies Revenue (Million USD) and Market Share by Region (2013-2018)
    Table EMEA Biosimilar Monoclonal Antibodies Revenue Share by Region (2013-2018)
    Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Region (2013-2018)
    Figure EMEA Biosimilar Monoclonal Antibodies Revenue Market Share Regions in 2017
    Table EMEA Biosimilar Monoclonal Antibodies Sales Price (USD/Unit) by Region (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Market Share by Type (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Market Share by Type in 2017
    Table Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Market Share by Application (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Market Share by Application in 2017
    Table Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Countries (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2017
    Table Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) by Countries (2013-2018)
    Table Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2017
    Figure Germany Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure France Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure UK Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Russia Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Italy Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Benelux Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Middle East Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Middle East Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Table Middle East Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2013-2018)
    Table Middle East Biosimilar Monoclonal Antibodies Market Share by Type (2013-2018)
    Figure Middle East Biosimilar Monoclonal Antibodies Market Share by Type (2013-2018)
    Table Middle East Biosimilar Monoclonal Antibodies Sales (K Units) by Applications (2013-2018)
    Table Middle East Biosimilar Monoclonal Antibodies Market Share by Applications (2013-2018)
    Figure Middle East Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2017
    Table Middle East Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Countries (2013-2018)
    Table Middle East Biosimilar Monoclonal Antibodies Sales Volume Market Share by Countries (2013-2018)
    Figure Middle East Biosimilar Monoclonal Antibodies Sales Volume Market Share by Countries in 2017
    Table Middle East Biosimilar Monoclonal Antibodies Revenue (Million USD) by Countries (2013-2018)
    Table Middle East Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
    Figure Middle East Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
    Figure Middle East Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2017
    Figure Saudi Arabia Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Israel Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure UAE Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Iran Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2013-2018)
    Table Africa Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2013-2018)
    Table Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
    Table Africa Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2013-2018)
    Table Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
    Table Africa Biosimilar Monoclonal Antibodies Sales Volume (K Units) by Countries (2013-2018)
    Table Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2017
    Table Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) by Countries (2013-2018)
    Table Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
    Figure Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2017
    Figure South Africa Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Nigeria Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Egypt Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Algeria Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Basic Information List
    Table ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure ProMab Biotechnologies Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Allergan plc Biosimilar Monoclonal Antibodies Basic Information List
    Table Allergan plc Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Allergan plc Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Abbott Biosimilar Monoclonal Antibodies Basic Information List
    Table Abbott Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Abbott Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Abbott Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Abbott Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Basic Information List
    Table BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure BioXpress Therapeutics Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Bayer Biosimilar Monoclonal Antibodies Basic Information List
    Table Bayer Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Bayer Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Bayer Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Bayer Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Bio Farma Biosimilar Monoclonal Antibodies Basic Information List
    Table Bio Farma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Bio Farma Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Merck Biosimilar Monoclonal Antibodies Basic Information List
    Table Merck Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Merck Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Merck Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Merck Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Therapeutics Biosimilar Monoclonal Antibodies Basic Information List
    Table Therapeutics Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Therapeutics Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Biocon Biosimilar Monoclonal Antibodies Basic Information List
    Table Biocon Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Biocon Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Basic Information List
    Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate (2013-2018)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales Market Share in EMEA (2013-2018)
    Figure Boehringer Ingelheim Biosimilar Monoclonal Antibodies Revenue Market Share in EMEA (2013-2018)
    Table Celltrion Inc. Biosimilar Monoclonal Antibodies Basic Information List
    Table Coherus BioSciences Inc. Biosimilar Monoclonal Antibodies Basic Information List
    Table Zydus-Cadila Biosimilar Monoclonal Antibodies Basic Information List
    Table Genor BioPharma Biosimilar Monoclonal Antibodies Basic Information List
    Table Intas Pharmaceuticals Biosimilar Monoclonal Antibodies Basic Information List
    Table Novartis Biosimilar Monoclonal Antibodies Basic Information List
    Table Pfizer Biosimilar Monoclonal Antibodies Basic Information List
    Table Reliance Life Sciences Biosimilar Monoclonal Antibodies Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
    Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
    Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2017
    Table Major Buyers of Biosimilar Monoclonal Antibodies
    Table Distributors/Traders List
    Figure EMEA Biosimilar Monoclonal Antibodies Sales (K Units) and Growth Rate Forecast (2018-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2018-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Price (USD/Unit) and Trend Forecast (2018-2025)
    Table EMEA Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Region (2018-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Region (2018-2025)
    Table EMEA Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Region (2018-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Region (2018-2025)
    Table Europe Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Countries (2018-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Countries (2018-2025)
    Table Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Countries (2018-2025)
    Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Countries (2018-2025)
    Table Middle East Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Countries (2018-2025)
    Figure Middle East Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Countries (2018-2025)
    Table Middle East Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Countries (2018-2025)
    Figure Middle East Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Countries (2018-2025)
    Table Africa Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Countries (2018-2025)
    Figure Africa Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Countries (2018-2025)
    Table Africa Biosimilar Monoclonal Antibodies Revenue (Million USD) Forecast by Countries (2018-2025)
    Figure Africa Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Countries (2018-2025)
    Table EMEA Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Type (2018-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type (2018-2025)
    Table EMEA Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Application (2018-2025)
    Figure EMEA Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.